InfoBionic, Inc. announced that it will receive $65,442,033 in funding on September 29, 2023. The company will issue 111,690,245 series D-1 participating preferred shares at issue price of $0.1343 per share for the gross proceeds $14,999,999.9035; 281,515,118 series D-2 non-participating preferred shares at issue price of $0.1614 per share for the gross proceeds $45,436,540.0452; and 37,230,080 series D-3 non-participating preferred shares at issue price of $0.1343 per share for the gross proceeds $4,999,999.744. The shares are issued at $0.0001 par value per share.

The shares are convertible, and redeemable. The shares will be convertible in common shares at a price of $0.1343; $0.1614; and $0.1343 per share respectively. The round will be raised at post money valuation of $69,812,618.

The company will issue securities pursuant to exemption provided under Regulation D.